Translational research into new strategies for diagnosis and treatment of disease liver. PI: Wladimiro Jimenez

Presentation

Our group is aimed at investigating the pathophysiological and molecular bases of the most frequent complications occurring in patients with chronic liver disease. All projects have a profound translational character, with special interest in identifying new therapeutic tools to stop or reverse the fibro-proliferative processes. We are committed to identify either, new biomarkers of liver injury and novel fibrogenesis signaling pathways. We also want to inhibit the activity of FoxO1 in hepatocytes or to modify the activity of specific targets of Akt with therapeutic potential. The general objective would be to stimulate functional liver regeneration in cirrhotic livers. Our research is also aimed at evaluating the therapeutic potential of Cerium oxide nanoparticles (CeO2NPs). These studies are carried out in experimental models of liver fibrosis, hepatocellular carcinoma and non-alcoholic steato hepatitis. Finally, we are developing cellular therapies to stimulate the regenerative capacity of cirrhotic livers by means of carbon nanoparticles that containing expression plasmids activating M2 phenotype.

Wladimiro Jimenez
PhD Associate professor
wjimenez@ub.edu

Manuel Morales Ruiz
PhD Assistant professor
morales@clinic.cat

Guillermo Fernández Varo
PhD CIBERehd researcher
guillermo.fernandez@ciberehd.org

Jordi Ribera Sabaté
PhD CIBERehd researcher
jordi.ribera@ciberehd.org

Gregori Casals Mercadal
PhD Senior specialist, Hospital Clínic
casals@clinic.cat

Esther Fernández Galán
Especialist, Hospital Clínic
esfernandez@clinic.cat

Marina Parra Robert
Especialist, Hospital Clínic
mparra@clinic.cat

Pedro Melgar Lesmes
PhD Postdoctoral researcher, Ramon y Cajal
pmelgar@ub.edu

Carmen Belén González
Laboratory technician, IDIBAPS
cbgonzalez@clinic.cat

Alazne Moreno Lanceta

FPI Fellow Researcher, IDIBAPS
amorenol@clinic.cat

Mirieia Medrano Bosch
FPU Predoctoral Fellow
mmedranobosch@ub.edu

Elena Lecue Costas
Predoctoral Researcher, IDIBAPS
elecuecostas@gmail.com

Meritxell Perramon Corominas
Predoctoral Researcher, IDIBAPS
meri.perramon@gmail.com

  • To identify non-invasive biomarkers of liver injury and new signaling pathways of liver fibroproliferative processes.
  • To evaluate new strategies to inhibit hapatocyte activity of FoxO1 or to modify the activity of specific Akt targets that have a therapeutic potential to stimulate functional liver regeneration in cirrhotic livers.
  • To establish new therapies for the normalization of the intrahepatic vasculature in cirrhotic livers.
  • To evaluate the therapeutic potential of cerium oxide nanoparticles in experimental models of hepatocarcinoma and liver steatosis.
  • To evaluate the utility of matrix implants of collagen containing endothelial cells as cell therapy to stimulate the regenerative capacity of cirrhotic livers.
  • Modulation of macrophages to liver damage, regeneration and cancer through functionalized nanoparticles and gene therapy.

Incorporación de la espectrometría de masas en las pruebas de endocrinología y nutrición

PI: Gregori Casals
Financing entity: Sociedad Española de Endocrinología y Nutrición
Ref.: Investigación Clínica en Endocrinología General y Metabolismo
Amount: 10.000,00 €
15/10/21 to15/10/22

Effect of long term administration of a specific cb2 agonist on hepatic collagen content in rats with fibrosis

PI: Wladimiro Jiménez Povedano
Financing entity: ABALON BIO INC.
2021

Effect of a new formulation of human serum albumin on systemic hemodynamics, inflammatory mediators and oxidative stress in rats with cirrhosis and ascites

PI: Wladimiro Jiménez Povedano
Financing entity: European Foundation for the Study of Chronic Liver Failure
09/05/2016 still in force

THERANANO: Determining the therapeutic use in liver diseases of advanced antioxidant conjugates based on cerium oxide nanoparticles

PIs: Gregori Casals Mercadal and Guillermo Fernández Varo
Financing entity: Instituto de Salud Carlos III
Ref: PI19-00774
Amount: 147.620 €
01/01/2020 to 31/12/2022

Identification of  novel serological biomarkers pf liver fibrosis resolution in rats with CCl4 Induced fibrosis

IP:Wladimiro Jiménez Povedano
Entitat finançadora: Nordic Bioscience
2021

Utilidad terapeutica y de nuevos tratamientos para las enfermedades hepáticas. RNA de interferencia para PTTG1. Nanoparticulas de carbono grafito y donadores de óxido nítrico

PI: Wladimiro Jiménez Povedano
Financing entitya: Ministerio de Ciencia, Innovación y Universidades
Ref.: RTI2018-094734-B-C21
Amount: 190.000 €
04/10/2016 to 31/12/2021

Effect of a new CD6-Derived peptide (SEP3) on systemic  hemodynamics in endotexemic rats induced by lipopolysaccharide (LPS) administration

PI: Wladimiro Jiménez Povedano
Financing entity: Sepsia Therapeutics SL
2020 to 2021

Development and application of ceria nanoparticles in the treatment of hepatocellular carcinoma

PI: Wladimiro Jiménez Povedano
Financing entity: Agència de gestió d’ajuts universitaris i de recerca. Ayudas de industria de Conocimiento (Llavor i Producte)
Ref.: 2018_PROD_00187
Amount: 41.850 €
01/05/2019 to 31/01/2021

Nuevos mecanismos moleculares y nuevas estrategias terapéuticas aplicables a la conservación de la función hepática y a la mejora de la enfermedad hepática crónica

PI: Manuel Morales-Ruiz
Financing entity: Agencia Estatal de Investigación, Ministerio de Ciencia  Innovación
Ref.: PID2019-105502RB-100
01/01/2019 to 31/12/2020

Ceria nanoparticles for use in the treatment of hepatocellular carcinoma

PIs: Wladimiro Jimenez Povedano and Victor Franco Puntes.
Financing entity: CERCA-GINJOL
Ref.: 2017-02-002-CeNPsHCC-IDIBAPS
01/01/2017 to 31/12/2019

Evaluación de las propiedades antioxidantes y antiinflamatorias de las nanopartículas de óxido de cerio como nueva estrategia terapéutica en la esteatosis hepática

PI: Gregori Casals Mercadal
Financing entity: Instituto de Salud Carlos III
Ref.: PI15/00777
Amount: 56.265 €
01/01/2016 to 31/12/2018

Utilidad terapéutica de las nanopartículas de óxido de cerio en las enfermedades hepáticas

PIs: Wladimiro Jiménez Povedano and Guillermo Fernández Varo
Entitat finançadora: Ministerio de Economía y Competitividad
Ref.: SAF2015-64126-R
Amount: 180.000 €
01/01/2016 to 31/12/2018

Utilitat terapèutica de les nanopartícules d’óxid de ceri en la malaltia hepàtica

PI: Wladimiro Jiménez Povedano
Financing entity: PERIS
Ref.: 2016-2020 SLT002/16/0034
01/04/2017 to 31/08/2018

For more information for PI publications click in the link:

ORCID Wladimiro Jimenez: 0000-0002-9376-0214
ORCID Manuel Morales: 0000-0002-9074-2272
ORCID Gregori Casals: 0000-0002-3271-1371
ORCID Pedro Melgar: 0000-0002-2009-5911
ORCID Guillermo Fernandez-Varo: 0000-0002-7776-3300

 

Fernández-Galán E, Badenas C, Fondevila C, Jiménez W, Navasa M, Puig-Butillé JA, Brunet M. Monitoring of Donor-Derived Cell-Free DNA by Short Tandem Repeats: Concentration of Total Cell-Free DNA and Fragment Size for Acute Rejection Risk Assessment in Liver Transplantation. Liver Transpl. 2022 Feb; 28(2): 257-268. doi: 10.1002/ lt.26272. Epub 2021 Oct 4. PMID: 34407295

Meritxell Perramón, Silvia Carvajal, Vedrana Reichenbach, Guillermo Fernández-Varo, Loreto Boix Laura Macias-Muñoz, Pedro Melgar-Lesmes,| Jordi Bruix, Shlomo Melmed, Santiago Lamas, Wladimiro Jiménez. The pituitary tumor‐transforming gene 1 / delta like homolog 1 pathway plays a key role in liver fibrogenesis Liver International Wiley. Liver int. 2022 Jan 20. doi: 10.1111/liv.15165. Online ahead of print. PMID: 35050550

Juanola A, Graupera I, Elia C, Piano S, Solé C, Carol M, Pérez-Guasch M, Bassegoda O, Escudé L, Rubio AB, Cervera M, Napoleone L, Avitabile E, Ma AT, Fabrellas N, Pose E, Morales-Ruiz M, Jiménez W, Torres F, Crespo G, Solà E, Ginès P. Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis. J Hepatol. 2022 Jan; 76(1): 107-114. doi: 10.1016/ j.jhep.2021.08.031. Epub 2021 Sep 13. PMID: 34530063

García-Eguren G, González-Ramírez M, Vizán P, Giró O, Vega-Beyhart A, Boswell L, Mora M, Halperin I, Carmona F, Gracia M, Casals G, Squarcia M, Enseñat J, Vidal O, Di Croce L, Hanzu FA. Glucocorticoid-induced Fingerprints on Visceral Adipose Tissue Transcriptome and Epigenome. J Clin Endocrinol Metab. 2022 Jan 1;107(1):150-166. doi: 10.1210/clinem/dgab662. PMID: 34487152

Ribera J, Portolés I, Córdoba-Jover B, Rodríguez-Vita J, Casals G, González-de la Presa B, Graupera M, Solsona-Vilarrasa E, Garcia-Ruiz C, Fernández-Checa JC, Soria G, Tudela R, Esteve-Codina A, Espadas G, Sabidó E, Jiménez W, Sessa WC, Morales-Ruiz M. The loss of DHX15 impairs endothelial energy metabolism, lymphatic drainage and tumor metastasis in mice. Commun Biol. 2021 Oct 15; 4(1): 1192. doi: 10.1038/ s42003-021-02722-w. PMID: 34654883

Zeng M, Shu Y, Parra-Robert M, Desai D, Zhou H, Li Q, Rong Z, Karaman DŞ, Yang H, Peng J, Fernandez-Varo G, Jiménez W, Casals G, Puntes V, Rosenholm JM, Casals E. Scalable synthesis of multicomponent multifunctional inorganic core@mesoporous silica shell nanocomposites. Mater Sci Eng C Mater Biol Appl. 2021 Sep; 128: 112272. doi: 10.1016/ j.msec.2021.112272. Epub 2021 Jun 24. PMID: 34474831

Guerra Ruiz, Armando Raúl, Crespo, Javier, López Martínez, Rosa Maria, Iruzubieta, Paula, Casals Mercadal, Gregori, Lalana Garcés, Marta, Lavin, Bernardo and Morales Ruiz, Manuel. Measurement and clinical usefulness of bilirubin in liver disease. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, vol. 2, no. 3, 2021, pp. 352-361.

Vega-Beyhart A, Iruarrizaga M, Pané A, García-Eguren G, Giró O, Boswell L, Aranda G, Flores V, Casals G, Alonso C, Mora M, Halperin I, Carmona F, Enseñat J, Vidal O, Hu T, Rojo G, Gomis R, Hanzu FA. Endogenous cortisol excess confers a unique lipid signature and metabolic network. J Mol Med (Berl). 2021 Aug;99(8): 1085-1099. doi: 10.1007/ s00109-021-02076-0. Epub 2021 Apr 21. PMID: 33881561.

Medrano-Bosch M, Moreno-Lanceta A, Melgar-Lesmes P. Nanoparticles to Target and Treat Macrophages: The Ockham's Concept? Pharmaceutics. 2021 Aug 26; 13(9):1340. doi: 10.3390/ pharmaceutics13091340. PMID: 34575416 

Parra-Robert M, Zeng M, Shu Y, Fernández-Varo G, Perramón M, Desai D, Chen J, Guo D, Zhang X, Morales-Ruiz M, Rosenholm JM, Jiménez W, Puntes V, Casals E, Casals G. Mesoporous silica coated CeO2 nanozymes with combined lipid-lowering and antioxidant activity induce long-term improvement of the metabolic profile in obese Zucker rats. Nanoscale. 2021 May 14; 13(18): 8452-8466. doi: 10.1039/ d1nr00790d. Epub 2021 Apr 14. PMID: 33984104

Wijngaard R, Perramón M, Parra-Robert M, Hidalgo S, Butrico G, Morales-Ruiz M, Zeng M, Casals E, Jiménez W, Fernández-Varo G, Shulman GI, Cline GW, Casals G. Validation of a Gas Chromatography-Mass Spectrometry Method for the Measurement of the Redox State Metabolic Ratios Lactate/Pyruvate and β-Hydroxybutyrate / Acetoacetate in Biological Samples. Int J Mol Sci. 2021 Apr 30; 22(9). doi: 10.3390/ ijms22094752. PMID: 33946157

Ribera J, Vilches C, Sanz V, de Miguel I, Portolés I, Córdoba-Jover B, Prat E, Nunes V, Jiménez W, Quidant R, Morales-Ruiz M. Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia. ACS Nano. 2021 Apr 27; 15(4): 7547-7562. doi: 10.1021/ acsnano.1c00988. Epub 2021 Mar 15. PMID: 33720693. 

Casals G, Perramón M, Casals E, Portolés I, Fernández-Varo G, Morales-Ruiz M, Puntes V, Jiménez W. Cerium Oxide Nanoparticles: A New Therapeutic Tool in Liver Diseases. Antioxidants (Basel). 2021 Apr 24; 10(5). doi: 10.3390/ antiox10050660. Review. PMID: 33923136

Araujo-Castro M, Valderrábano P, Escobar-Morreale HF, Hanzu FA, Casals G. Urine steroid profile as a new promising tool for the evaluation of adrenal tumors. Literature review. Endocrine. 2021 Apr; 72(1):40-48. doi: 10.1007 /s12020-020-02544-6. Epub 2020 Nov 21. PMID: 33219921.

Guerra-Ruiz, Armando R., Casals, Gregori, Iruzubieta, Paula, Lalana, Marta, Leis, Alba, López, Rosa María, Crespo, Javier and Morales-Ruiz, Manuel. Biochemical assessment of metabolic associated fatty liver disease. 2021 March. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, vol. 2, no. 2, 2021, pp. 199-208. doi; 10.1515/almed-2021-0009.

Macias-Muñoz L, Wijngaard R, González-de la Presa B, Bedini JL, Morales-Ruiz M, Jiménez W. Value of clinical laboratory test for early prediction of mortality in patients with COVID-19: the BGM score. J Circ Biomark. 2021 Feb 8; 10:1-8. doi: 10.33393/ jcb.2021.2194. eCollection Jan-Dec 2021. PMID: 33717357

Leitner S, Solans C, García-Celma MJ, Morral-Ruíz G, Melgar-Lesmes P, Calderó G. Ethylcellulose nanoparticles prepared from nano-emulsion templates as new folate binding haemocompatible platforms. Mater Sci Eng C Mater Biol Appl. 2021 Jan; 120:111682. doi: 10.1016  /j.msec.2020.111682. Epub 2020 Oct 27. PMID: 33545844 

Fernández-Varo G, Perramón M, Carvajal S, Oró D, Casals E, Boix L, Oller L, Macías-Muñoz L, Marfà S, Casals G, Morales-Ruiz M, Casado P, Cutillas PR, Bruix J, Navasa M, Fuster J, Garcia-Valdecasas JC, Pavel MC, Puntes V, Jiménez W. Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma. Hepatology. 2020 Oct; 72(4): 1267-1282. doi: 10.1002/ hep.31139. PMID: 31961955

Bosch X, Jáuregui B, Villamor N, Morales-Ruiz M, Ortiz-Pérez JT, Borràs R, Penela D, Soto-Iglesias D, Perea RJ, Doltra A, Prat-González S, Jiménez W, Mira Á, Lasalvia L, Berruezo A. Monocyte Subsets Are Differently Associated with Infarct Size, Left Ventricular Function, and the Formation of a Potentially Arrhythmogenic Scar in Patients with Acute Myocardial Infarction. J Cardiovasc Transl Res. 2020 Oct; 13(5): 722-730. doi: 10.1007/ s12265-019- 09944-8. Epub 2019 Dec 12. PMID: 31833003 

Moreno-Lanceta A, Medrano-Bosch M, Melgar-Lesmes P.. Single-Walled Carbon Nanohorns as Promising Nanotube-Derived Delivery Systems to Treat Cancer. Pharmaceutics. 2020 Sep 7;12(9):850. doi: 10.3390/ pharmaceutics12090850. PMID: 32906852 

Casals G, Hanzu FA. Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry? Ann Lab Med. 2020 Jul; 40(4): 285-296. doi: 10.3343/ alm.2020.40.4.285. PMID: 32067427

Casals E, Zeng M, Parra-Robert M, Fernández-Varo G, Morales-Ruiz M, Jiménez W, Puntes V, Casals G. Cerium Oxide Nanoparticles: Advances in Biodistribution, Toxicity, and Preclinical Exploration. Small. 2020 May; 16(20) :e1907322. doi: 10.1002/ smll.201907322. Epub 2020 Apr 24. Review. PMID: 32329572

Jáuregui B, Soto-Iglesias D, Penela D, Acosta J, Fernández-Armenta J, Linhart M, Terés C, Syrovnev V, Zaraket F, Hervàs V, Prat-González S, Perea RJ, Morales-Ruiz M, Jiménez W, Lasalvia L, Bosch X, Ortiz-Pérez JT, Berruezo A. Follow-Up After Myocardial Infarction to Explore the Stability of Arrhythmogenic Substrate: The Footprint Study. JACC Clin Electrophysiol. 2020 Feb; 6(2): 207-218. doi: 10.1016/ j.jacep.2019.10.002. Epub 2019 Nov 27. PMID: 32081225.

Carvajal S, Perramón M, Casals G, Oró D, Ribera J, Morales-Ruiz M, Casals E, Casado P, Melgar-Lesmes P, Fernández-Varo G, Cutillas P, Puntes V, Jiménez W. Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes. Int J Mol Sci. 2019 Nov 27; 20(23). doi: 10.3390 /ijms20235959. PMID: 31783479

Córdoba-Jover B, Arce-Cerezo A, Ribera J, Pauta M, Oró D, Casals G, Fernández-Varo G, Casals E, Puntes V, Jiménez W, Morales-Ruiz M. Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats. J Nanobiotechnology. 2019 Oct 31; 17(1): 112. doi: 10.1186/ s12951- 019-0544-5. PMID: 31672158

Melgar-Lesmes P, Perramon M, Jiménez W. Roles of the Hepatic Endocannabinoid and Apelin Systems in the Pathogenesis of Liver Fibrosis. Cells. 2019 Oct 24; 8(11). doi: 10.3390/cells8111311. Review. PMID: 31653030

Carvajal S, Perramón M, Oró D, Casals E, Fernández-Varo G, Casals G, Parra M, González de la Presa B, Ribera J, Pastor Ó, Morales-Ruíz M, Puntes V, Jiménez W. Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Sci Rep. 2019 Sep 6; 9(1): 12848. doi: 10.1038/ s41598-019-49262-2. PMID: 31492960

Parra-Robert M, Casals E, Massana N, Zeng M, Perramón M, Fernández-Varo G, Morales-Ruiz M, Puntes V, Jiménez W, Casals G. Beyond the Scavenging of Reactive Oxygen Species (ROS): Direct Effect of Cerium Oxide Nanoparticles in Reducing Fatty Acids Content in an In Vitro Model of Hepatocellular Steatosis. Biomolecules. 2019 Aug 29; 9(9). doi: 10.3390 /biom9090425. PMID: 31470518

Huelin P, Solà E, Elia C, Solé C, Risso A, Moreira R, Carol M, Fabrellas N, Bassegoda O, Juanola A, de Prada G, Albertos S, Piano S, Graupera I, Ariza X, Napoleone L, Pose E, Filella X, Morales-Ruiz M, Rios J, Fernández J, Jiménez W, Poch E, Torres F, Ginès P. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study. Hepatology. 2019 Jul; 70(1): 319-333. doi: 10.1002/ hep.30592. Epub 2019 Apr 25. PMID: 30810244.

Solé C, Solà E, Huelin P, Carol M, Moreira R, Cereijo U, Mas JM, Graupera I, Pose E, Napoleone L, dePrada G, Juanola A, Fabrellas N, Torres F, Morales-Ruiz M, Farrés J, Jiménez W, Ginès P. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival. Liver Int. 2019 Jul; 39(7): 1246-1255. doi: 10.1111/ liv.14037. Epub 2019 Feb 17. PubMed PMID: 30597709

Ribera J, Rodríguez-Vita J, Cordoba B, Portolés I, Casals G, Casals E, Jiménez W, Puntes V, Morales-Ruiz M. Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats. PLoS One. 2019 Jun 24; 14(6): e0218716. doi: 10.1371/ journal.pone.0218716. eCollection 2019. PMID: 31233564 

Huelin P, Solà E, Elia C, Solé C, Risso A, Moreira R, Carol M, Fabrellas N, Bassegoda O, Juanola A, de Prada G, Albertos S, Piano S, Graupera I, Ariza X, Napoleone L, Pose E, Filella X, Morales-Ruiz M, Rios J, Fernández J, Jiménez W, Poch E, Torres F, Ginès P. Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study. Hepatology. 2019 Feb 27. doi: 10.1002/ hep.30592. [Epub ahead of print]. PMID: 30810244

Solé C, Solà E, Huelin P, Carol M, Moreira R, Cereijo U, Mas JM, Graupera I, Pose E, Napoleone L, dePrada G, Juanola A, Fabrellas N, Torres F, Morales-Ruiz M, Farrés J, Jiménez W, Ginès P. Characterization of inflammatory response in hepatorenal syndrome: Relationship with kidney outcome and survival. Liver Int. 2018 Dec 29. doi: 10.1111 /liv.14037. [Epub ahead of print] PMID: 30597709

Melgar-Lesmes P, Luquero A, Parra-Robert M, Mora A, Ribera J, Edelman ER, Jiménez W. Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy. Nano Lett. 2018 Sep 12;18(9): 5839-5845. doi: 10.1021/ acs.nanolett.8b02498. Epub 2018 Aug 16. PMID: 30096241

Melgar-Lesmes P, Sánchez-Herrero A, Lozano-Juan F, de la Torre Hernández JM, Montell E, Jiménez W, Edelman ER, Balcells M. Chondroitin sulfate attenuates atherosclerosis in ApoE Knockout mice involving cellular regulation of the inflammatory response. Thromb Haemost. 2018 Jul;118(7): 1329-1339. doi: 10.1055/ s-0038-1657753. Epub 2018 Jun 6. PMID: 29874688

Fernández-Galán E, Massana N, Parra-Robert M, Hidalgo S, Casals G, Esteve J, Jiménez W. Validation of a routine gas chromatography mass spectrometry method for 2-hydroxyglutarate quantification in human serum as a screening tool for detection of idh mutations. J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Apr 15;1083: 28-34. doi: 10.1016 /j.jchromb. 2018.02.038. Epub 2018 Feb 28. PMID: 29522955

Lopez-Moya M, Melgar-Lesmes P, Kolandaivelu K, de la Torre Hernández JM, Edelman ER, Balcells M.Tweaking glutaraldehyde-fixed tissue heart valves with chondroitin sulfate hydrogel for endothelialization and shield against deterioration. Biomacromolecules. 2018 Apr 9;19(4):1234-1244. doi: 10.1021/ acs.biomac.8b00077. Epub 2018 Mar 20. PMID: 29539266

Lopez-Moya M, Melgar-Lesmes P, Kolandaivelu K, de la Torre Hernández JM, Edelman ER, Balcells M. Optimizing Glutaraldehyde-Fixed Tissue Heart Valves with Chondroitin Sulfate Hydrogel for Endothelialization and Shielding against Deterioration. Biomacromolecules. 2018 Apr 9;19(4): 1234-1244. doi: 10.1021/ acs.biomac. 8b00077. Epub 2018 Mar 20. PMID: 29539266

Auge JM, Rodriguez C, Espanyol O, Rivero L, Sandalinas S, Grau J, Jimenez W, Castells A. An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer. Clin Chem Lab Med. 2018 Mar 28; 56(4): 625-633. doi: 10.1515/cclm- 2017-0605. PMID: 29150989

Aranda G, Fernandez-Ruiz R, Palomo M, Romo M, Mora M, Halperin I, Casals G, Enseñat J, Vidal O, Diaz-Ricart M, Hanzu FA. Translational evidence of prothrombotic and inflammatory endothelial damage in Cushing syndrome after remission. Clin Endocrinol (Oxf). 2018 Mar; 88(3):415-424. doi: 10.1111/ cen.13521. Epub 2017 Dec 17. PMID: 29154455

Miró Ò, González de la Presa B, Herrero-Puente P, Fernández Bonifacio R, Möckel M, Mueller C, Casals G, Sandalinas S, Llorens P, Martín-Sánchez FJ, Jacob J, Bedini JL, Gil V. The GALA study: relationship between galectin-3 serum levels and short- and long-term outcomes of patients with acute heart failure. Biomarkers. 2017 Dec; 22(8): 731-739. doi: 10.1080/1354750X. 2017.1319421. Epub 2017 May 2. PMID: 28406038

Ribera J, Pauta M, Melgar-Lesmes P, Córdoba B, Bosch A, Calvo M, Rodrigo-Torres D, Sancho-Bru P, Mira A, Jiménez W, Morales-Ruiz M. A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury. Am J Physiol Gastrointest Liver Physiol. 2017 Nov 1;313(5): G492-G504. doi: 10.1152/ ajpgi.00428. 2016. Epub 2017 Aug 10. PMID: 28798084

Aranda G, Lopez C, Fernandez-Ruiz R, Esteban Y, Garcia-Eguren G, Mora M, Halperin I, Casals G, Enseñat J, Hanzu FA. Circulatory Immune Cells in Cushing Syndrome: Bystanders or Active Contributors to Atherometabolic Injury? A Study of Adhesion and Activation of Cell Surface Markers. Int J Endocrinol. 2017; 2017: 2912763. doi: 10.1155/ 2017/2912763. Epub 2017 Sep 20. PMID: 29213284

Casals E, Gusta MF, Piella J, Casals G, Jiménez W, Puntes V. Intrinsic and Extrinsic Properties Affecting Innate Immune Responses to Nanoparticles: The Case of Cerium Oxide. Front Immunol. 2017 Aug 14;8:970. doi: 10.3389/ fimmu. 2017.00970. eCollection 2017. Review. Erratum in: Front Immunol. 2017 Dec 22;8:1891. PMID: 28855907

Garcia-Polite F, Martorell J, Del Rey-Puech P, Melgar-Lesmes P, O'Brien CC, Roquer J, Ois A, Principe A, Edelman ER, Balcells M. Pulsatility and high shear stress deteriorate barrier phenotype in brain microvascular endothelium. J Cereb Blood Flow Metab. 2017 Jul; 37(7): 2614-2625. doi: 10.1177/ 0271678X16672482. Epub 2016 Jan 1. PMID: 27702879

Melgar-Lesmes P, Balcells M, Edelman ER. Implantation of healthy matrix-embedded endothelial cells rescues dysfunctional endothelium and ischaemic tissue in liver engraftment. Gut. 2017 Jul; 66(7): 1297-1305. doi: 10.1136/ gutjnl- 2015-310409. Epub 2016 Feb 5. PMID: 26851165

Pericàs JM, García-de-la-Mària C, Brunet M, Armero Y, García-González J, Casals G, Almela M, Quintana E, Falces C, Ninot S, Fuster D, Llopis J, Marco F, Moreno A, Miró JM; Hospital Clinic Endocarditis Study Group. Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis. J. Antimicrob Chemother. 2017 Jun 1;72(6): 1714-1722. doi: 10.1093 /jac/dkx016. PMID: 28204495

Graupera I, Coll M, Pose E, Elia C, Piano S, Solà E, Blaya D, Huelin P, Solé C, Moreira R, de Prada G, Fabrellas N, Juanola A, Morales-Ruiz M, Sancho-Bru P, Villanueva C, Ginès P. Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes. Sci Rep. 2017 May 12;7(1): 1829. doi: 10.1038/ s41598-017-01709-0. PMID: 28500294

Solà E, Sanchez-Cabús S, Rodriguez E, Elia C, Cela R, Moreira R, Pose E, Sánchez-Delgado J, Cañete N, Morales-Ruiz M, Campos F, Balust J, Guevara M, García-Valdecasas JC, Ginès P. Effects of alfapump™ system on kidney and circulatory function in patients with cirrhosis and refractory ascites. Liver Transpl. 2017 May; 23(5): 583-593. doi: 10.1002/ lt.24763. PMID: 28318147

Soto M, Sampietro-Colom L, Lasalvia L, Mira A, Jiménez W, Navasa M. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients. World Journal of Gastroenterology, 2017 May 7;23(17): 3163-3173. doi: 10.3748/ wjg.v23.i17.3163. PMID. 28533673

Penela D, Acosta J, Andreu D, Ortiz-Perez JT, Bosch X, Perea RJ, de Caralt TM, Fernández-Armenta J, Soto-Iglesias D, Prat-Gonzalez S, Borràs R, Mont L, Hervas V, Morales-Ruiz M, Jiménez W, Mira A, Donnelly J, Ekinci O, Lasalvia L, Berruezo A. Identification of the potentially arrhythmogenic substrate in the acute phase of ST-segment elevation myocardial infarction. Heart Rhythm. 2017 Apr; 14(4): 592-598. doi: 10.1016/j.hrthm. 2017.01.019. Epub 2017 Jan 17. PMID: 28104481

Sans-Roselló J, Casals G, Rossello X, González de la Presa B, Vila M, Duran-Cambra A, Morales-Ruiz M, Ferrero-Gregori A, Jiménez W, Sionis A. Prognostic value of plasma apelin concentrations at admission in patients with ST-segment elevation acute myocardial infarction. Clin Biochem. 2017 Apr; 50(6): 279-284. doi: 10.1016/ j.clinbiochem. 2016.11.018. Epub 2016 Nov 24. PMID: 27889567

Reyes A, Marti J, Marfà S, Jiménez W, Reichenbach V, Pelegrina A, Fondevila C, Garcia Valdecasas JC, Fuster J. Prognostic prediction by liver tissue proteomic profiling in patients with colorectal liver metastases. Future Oncol. 2017 Apr; 13(10): 875-882. doi: 10.2217/ fon-2016-0461. Epub 2017 Jan 16.

Morales-Ruiz M, Santel A, Ribera J, Jiménez W. The Role of Akt in Chronic Liver Disease and Liver Regeneration. Semin Liver Dis. 2017 Feb; 37(1): 11-16. doi: 10.1055/ s-0036- 1597819. Epub 2017 Feb 15. PMID: 28201844

Escoté X, Aranda GB, Mora M, Casals G, Enseñat J, Vidal O, Esteban Y, Halperin I, Hanzu FA. Zinc alpha-2 glycoprotein is overproduced in Cushing's syndrome. Endocrinol Diabetes Nutr. 2017 Jan; 64(1):26-33. doi: 10.1016/ j.endinu. 2016.10.002. Epub 2017 Jan 18. English, Spanish. PMID: 28440767

Solà E, Kerbert AJ, Verspaget HW, Moreira R, Pose E, Ruiz P, Cela R, Morales-Ruiz M, López E, Graupera I, Solé C, Huelin P, Navarro AA, Ariza X, Jalan R, Fabrellas N, Benten D, de Prada G, Durand F, Jimenez W, van der Reijden JJ, Fernandez J, van Hoek B, Coenraad MJ, Ginès P. Plasma copeptin as biomarker of disease progression and prognosis in cirrhosis. J Hepatol. 2016 Nov; 65(5):914-920. doi: 10.1016 /j.jhep. 2016.07.003. Epub 2016 Jul 12. PMID: 27422752

Perea RJ, Morales-Ruiz M, Ortiz-Perez JT, Bosch X, Andreu D, Borras R, Acosta J, Penela D, Prat-González S, de Caralt TM, Martínez M, Morales-Romero B, Lasalvia L, Donnelly J, Jiménez W, Mira A, Mont L, Berruezo A. Utility of galectin-3 in predicting post-infarct remodeling after acute myocardial infarction based on extracellular volume fraction mapping. Int J Cardiol. 2016 Nov 15;223:458-464. doi: 10.1016/j.ijcard.2016.08.070. Epub 2016 Aug 8. PMID: 27544605

Marfà S, Marti J, Reyes A, Casals G, Fernández-Varo G, Carvajal S, García-Valdecasas JC, Fuster J, Jiménez W. Metastatic Tissue Proteomic Profiling Predicts 5-Year Outcomes in Patients with Colorectal Liver Metastases. Transl Oncol. 2016 Oct; 9(5): 445-452. doi: 10.1016/ j.tranon. 2016.08.002. PMID: 27751349

Aranda G, Careaga M, Hanzu FA, Patrascioiu I, Ríos P, Mora M, Morales-Romero B, Jiménez W, Halperin I, Casals G. Accuracy of immunoassay and mass spectrometry urinary free cortisol in the diagnosis of Cushing's syndrome. Pituitary 2016 Oct; 19(5): 496-502. doi: 10.1007/ s11102-016-0730-5. PMID: 27259502

Solé C, Solà E, Morales-Ruiz M, Fernàndez G, Huelin P, Graupera I, Moreira R, de Prada G, Ariza X, Pose E, Fabrellas N, Kalko SG, Jiménez W, Ginès P. Characterization of Inflammatory Response in Acute-on-Chronic Liver Failure and Relationship with Prognosis. Sci Rep. 2016 Aug 31; 6:32341. doi: 10.1038/srep32341. PMID: 27578545

X.Ariza, I.Graupera, M.Coll, R.Barreto, E.García, R. Moreira, C.Elia, M.Morales-Ruiz,, M.Llopis, P.Huelin, C.Solé, N.Fabrellas, E.Weiss, F.Nevens, A.Gerbes, J.Trebicka, F.Saliba, C.Fondevila, V.Hernández-Gea, J.Fernández, W.Jiménez, C.Deulofeu, M.Pavesi, P.Angeli, R.Jalan, R.Moreau, M.Bernardi, V.Arroyo, P.Sancho-Bru, and P.Ginès. Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. Journal Hepatology, 2016 Jul; 65(1): 57-65. doi:   10.1016/ j.jhep.2016.03.002. PMID: 26988732

G.Crespo, M.Gambato, O.Millán, G.Casals, P.Ruiz, M.C.Londoño, A.Mira, X.Forns, M.Brunet, W.Jimenez, M.Navasa. Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation. Transplant Infectious Disease, 2016 Jun;18(3):471-9. doi: 10.1111/tid.12526. PMID: 26992003

Crespo G, Gambato M, Millán O, Casals G, Ruiz P, Londoño MC, Mira A, Forns X, Brunet M, Jiménez W, Navasa M. Early non-invasive selection of patients at high risk of severe hepatitis C recurrence after liver transplantation. Transpl Infect Dis. 2016 Jun; 18(3): 471-9. doi: 10.1111/ tid.12526. Epub 2016 May 30. PMID: 26992003

Graupera I, Solà E, Fabrellas N, Moreira R, Solé C, Huelin P, de la Prada G, Pose E, Ariza X, Risso A, Albertos S, Morales-Ruiz M, Jiménez W, Ginès P. Urine Monocyte Chemoattractant Protein-1 Is an Independent Predictive Factor of Hospital Readmission and Survival in Cirrhosis. PLoS One. 2016 Jun 30;11(6): e0157371. doi: 10.1371/ journal.pone. 0157371. PMID: 27359339

Marfà S, Morales-Ruiz M, Oró D, Ribera J, Fernández-Varo G, Jiménez W. Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats. Biol Open. 2016 Jun 15; 5(6): 858-65. doi: 10.1242/ bio.018887. PMID: 27230648

M.Pauta, N.Rotllan, A. Fernandez-Hernando, C. Langhi, J.Ribera, L.Boix, J.Bruix, W.Jiménez, Y.Suarez, D.A.Ford, A.Baldan, M.Birnbaum, M.Morales-Ruiz, C.Fernandez-Hernando. Akt-mediated FoxO1 inhibition is required for liver regeneration after partial hepatectomy in mice. Hepatology, 2016 May; 63(5):1660-74.  doi: 10.1002/hep.28286. PMC: 5177729

Oró D, Yudina T, Fernández-Varo G, Casals E, Reichenbach V, Casals G, González de la Presa B, Sandalinas S, Carvajal S, Puntes V, Jiménez W. Cerium oxide nanoparticles reduce steatosis, portal hypertension and display antiinflammatory properties in rats with liver fibrosis. Journal Hepatology , 2016 Mar; 64(3):691-8. doi: 10.1016/ j.jhep. 2015.10.020. Epub 2015 Oct 28. PMID: 26519601

G.Fernández-Varo, D.Oró, E.E.Cable, V. Reichenbach, S. Carvajal, B. González de la Presa, K. Wiśniewski, P. Ginés, G. Harris, W. Jiménez. Vasopressin 1α receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Hepatology, 2016 Jan; 63(1):207-16. doi: 10.1002/ hep.28250. Epub 2015 Nov 4. PMID: 26403564

Auge JM, Fraser CG, Rodriguez C, Roset A, Lopez-Ceron M, Grau J, Castells A,  Jimenez W. Clinical utility of one versus two faecal immunochemical test samples in the detection of advanced colorectal neoplasia in symptomatic patients. Clin Chem Med Lab, 2016 Jan; 54(1): 125-32. doi: 10.1515/ cclm-2015-0388. PMID: 26124057

Melgar-Lesmes P,  Edelman ER. Monocyte-endothelial cell interactions in the regulation of vascular sprouting and liver regeneration in mouse. J Hepatol. 2015 Oct; 63(4): 917-25. doi: 10.1016 /j.jhep.2015.05.011. Epub 2015 May 27. PMID: 26022689

Ariza X, Solà E, Elia C, Barreto R, Moreira R, Morales-Ruiz M, Graupera I, Rodríguez E, Huelin P, Solé C, Fernández J, Jiménez W, Arroyo V, Ginès P. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS One. 2015, Jun 4;10(6):e0128145. doi: 10.1371/ journal.pone. 0128145. PMID: 26042740

Pauta M, Ribera J, Melgar-Lesmes P, Casals G, Rodríguez-Vita J, Reichenbach V, Fernandez-Varo G, Morales-Romero B, Bataller R, Michelena J, Altamirano J, Jiménez W, Morales-Ruiz M. Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition. Liver International. 2015 Apr; 35(4): 1383-92. doi: 10.1111/ liv.12505. Epub 2014 Mar 11. PMID: 24612347

Fabregat A,  Marcos J,  Ventura R, Casals G, Jimenez W, Reichenbach V, Segura J, Pozo OJ. Formation of Δ(1) and Δ(6) testosterone metabolites by human hepatocytes. Steroids 2015 Mar; 95:66-72. doi: 10.1016/ j.steroids.2014.12.006. Epub 2014 Dec 23. PMID: 25541059

Marfà S, Crespo G, Reichenbach V, Forns X, Casals G, Morales-Ruiz M, Navasa M, Jiménez W. Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease. PLoS One. 2014 Oct 2;9(10): e109254. doi: 10.1371/ journal.pone.0109254. eCollection 2014. PMID: 25275549

Lee MY, Luciano AK, Ackah E, Rodriguez-Vita J, Bancroft TA, Eichmann A, Simons M, Kyriakides TR, Morales-Ruiz M, Sessa WC. Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc Natl Acad Sci U S A; 2014 Sep 2; 111(35): 12865-70. doi: 10.1073/ pnas.1408472111. Epub 2014 Aug 18. PMID: 25136137

Auge JM, Pellise M, Escudero JM, Hernandez C, Andreu M, Grau J, Buron A, López-Cerón M, Bessa X, Serradesanferm A, Piracés M, Macià F, Guayta R, Filella X, Molina R, Jimenez W, Castells A. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program. Gastroenterology 2014 Sep; 147(3): 628-636.e1. doi: 10.1053/ j.gastro.2014.06.008. Epub 2014 Jun 14. PMID: 24937264

Filella X, Foj L, Alcover J, Augé JM, Molina R, Jiménez W. The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10μg/L. Clin Chim Acta. 2014 Sep 25; 436:303-7. doi: 10.1016/ j.cca.2014.06.019. Epub 2014 Jun 27. PMID: 24978824

Foj L, Milà M, Mengual L, Luque P, Alcaraz A, Jiménez W, Filella X. Real-time PCR PCA3 assay is a useful test measured in urine to improve prostate cancer detection. Clin Chim Acta. 2014 Aug 5; 435:53-8. doi: 10.1016/ j.cca.2014.04.025. Epub 2014 May 5. PMID: 24803095

Barreto R, Elia C, Solà E, Moreira R, Ariza X, Rodríguez E, Graupera I, Alfaro I, Morales-Ruiz M, Poch E, Guevara M, Fernández J, Jiménez W,  Arroyo V, Ginès P. Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections. J Hepatol. 2014 Jul; 61(1):35-42. doi: 10.1016/ j.jhep.2014.02.023. Epub 2014 Mar 5. PMID: 24613364

Casals G,  Oscar J.M., Pozo J., Alcaraz J, Martínez de Osaba MJ,  Jiménez W. Microwave-assisted derivatization: application to steroid profiling by gas chromatography/mass spectrometry. J Chromatography B 2014 Jun 1;960: 8-13. doi: 10.1016/ j.jchromb. 2014.04.015. Epub 2014 Apr 13. PMID: 24780701

  • Offers from the University of Barcelona:

Work UB

  • Offers from the Research Group:

At the moment, there are no job offers from this Research Group

Share: